 BETHESDA, Md., May 17, 2021 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Nasdaq: GANX Gain, a biotechnology company focused on redefining drug discovery by identifying and optimizing allosteric binding sites that have never before been targeted, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present a corporate overview at the 2021 RBC Capital Markets Global Healthcare Virtual Conference and at the Oppenheimer Rare Orphan Disease Summit, both taking place in May. 